Parkinson’s disease: Is there a light at the end of a tunnel? (Letter to the Editor)
Abstract
Parkinson’s disease is the second most common neu- rodegenerative disorder after Alzheimer disease affecting 1% - 2% in people >60 years old and 3% - 4% in people >80.
Share and Cite:
Surguchov, A. (2013) Parkinson’s disease: Is there a light at the end of a tunnel?.
Advances in Parkinson's Disease,
2, 116-117. doi:
10.4236/apd.2013.24022.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1]
|
Jankovic, J. (2008) Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 79, 368-376.
http://dx.doi.org/10.1136/jnnp.2007.131045
|
[2]
|
Surguchov, A. (2008) Molecular and cellular biology of synucleins. International Review of Cell and Molecular Biology, 270, 225-317.
http://dx.doi.org/10.1016/S1937-6448(08)01406-8
|
[3]
|
Bartels, T., Choi, J.G. and Selkoe, D.J. (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature, 477, 107-110.
http://dx.doi.org/10.1038/nature10324
|
[4]
|
Burré, J., Vivona, S., Diao, J., Sharma, M., Brunger, A.T. and Südhof, T.C. (2013) Properties of native brain α-synuclein. Nature, 498, E4-E6
http://dx.doi.org/10.1038/nature12125
|
[5]
|
Olanow, C.W. and Brundin, P. (2013) Parkinson’s disease and alpha synuclein: Is Parkinson’s disease a prion-like disorder? Movement Disorders, 28, 31-40.
http://dx.doi.org/10.1002/mds.25373
|